Prescriber Scope of Practice for Insomnia in Michigan

If you’re a psychiatrist or PMHNP considering telehealth for insomnia patients, you’ve probably asked yourself: Can I legally prescribe Ambien or other sleep meds through a video visit? The short answer in 2026 is yes — but the regulations are temporary, state-dependent, and about to change.

Here’s what you need to know to practice compliantly and build a sustainable insomnia telehealth practice.

The Federal Framework: DEA Telehealth Extensions Through 2026

Before COVID-19, the Ryan Haight Act made it illegal to prescribe controlled substances via telehealth without an initial in-person exam. That meant prescribing zolpidem (Ambien), eszopiclone (Lunesta), or any benzodiazepine for sleep required seeing the patient face-to-face first.

The pandemic changed everything. In March 2020, the DEA waived the in-person requirement, allowing providers to prescribe Schedule II–V controlled substances via telehealth if prescribing for a legitimate medical purpose and meeting the standard of care. This flexibility has been extended repeatedly — most recently through December 31, 2026.

What this means for you:

• You can initiate new patients on Schedule IV insomnia medications (zolpidem, eszopiclone, temazepam) via video consult
• No in-person exam required under current federal rules
• Prescriptions must be issued after a live audio-video evaluation (audio-only allowed only for buprenorphine)
• You must still comply with all state laws and PDMP requirements

What’s coming: The DEA is finalizing permanent telehealth prescribing rules that will likely include a Special Registration system. Under the proposed framework:

• Any DEA-registered provider could obtain a ‘Telemedicine Special Registration’ to prescribe Schedule III–V drugs (including most insomnia meds) without in-person exams
• Schedule II prescribing via telehealth would be limited to certain specialists — psychiatrists are specifically included
• A national PDMP system would be implemented as a safeguard

Bottom line: You have runway through 2026 under current flexibilities, but expect new registration requirements before 2027. Plan accordingly.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Understanding Insomnia Medications and Schedule Classifications

Most prescription insomnia medications are Schedule IV controlled substances:

Non-benzodiazepine hypnotics (‘Z-drugs’):

• Zolpidem (Ambien) — Schedule IV
• Eszopiclone (Lunesta) — Schedule IV
• Zaleplon — Schedule IV

Benzodiazepines:

• Temazepam (Restoril) — Schedule IV
• Triazolam — Schedule IV

Orexin receptor antagonists:

• Suvorexant (Belsomra) — Schedule IV
• Lemborexant — Schedule IV

Schedule IV classification means these medications have lower abuse potential than Schedule II stimulants or opioids, but they still require:

• A valid DEA registration
• PDMP checks (requirements vary by state)
• Appropriate documentation of medical necessity
• Adherence to refill limits (max 5 refills within 6 months)

Non-controlled options you can prescribe via telehealth without additional restrictions include trazodone, doxepin (low-dose), ramelteon, and antihistamines. These can be good first-line options for newer telehealth providers navigating state rules.

Psychiatrist vs PMHNP: Scope of Practice for Insomnia

Psychiatrists (MD/DO)

Your scope: Treating insomnia is squarely within your wheelhouse. You can:

• Diagnose primary insomnia and differentiate it from sleep disorders with psychiatric comorbidities
• Provide cognitive behavioral therapy for insomnia (CBT-I) or sleep hygiene counseling
• Prescribe any insomnia medication, controlled or not, without supervision
• Manage complex cases involving multiple psychiatric medications affecting sleep

No restrictions. As a physician, you have full prescriptive authority in any state where you’re licensed. No collaborative agreements, no formulary restrictions, no special permissions needed.

Regulatory considerations:

• You must be licensed in the state where the patient is located
• Maintain your DEA registration in each state of practice
• Follow state-specific PDMP requirements (varies by state)
• Document that your telehealth exam meets the same standard of care as in-person

The standard of care for insomnia includes: thorough sleep history, screening for medical causes (sleep apnea, restless leg syndrome), assessment of psychiatric comorbidities, discussion of behavioral interventions, and conservative medication management when appropriate.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Your scope depends on your state. This is where it gets complicated.

Full Practice Authority states (after experience requirements):

• New York: Independent practice after 3,600 hours under collaboration (~2 years)
• Illinois: Independent practice after 4,000 hours and additional training
• California: Moving toward independence under AB 890 (103/104 NP pathway)

In these states, experienced PMHNPs can diagnose and treat insomnia independently, prescribe Schedule IV sleep medications, and operate solo telehealth practices.

Reduced Practice states (collaborative agreement required):

• Pennsylvania: Must have written collaboration with a physician for prescriptive authority
• New York: (for NPs under 3,600 hours) collaboration required

Your collaborative agreement must specify controlled substance prescribing authority. The supervising physician doesn’t co-sign every prescription, but they must be available for consultation and periodic chart review.

Restricted Practice states (physician supervision required):

• Texas: Requires Prescriptive Authority Agreement with supervising physician. Critical limitation: Texas NPs cannot prescribe Schedule II controlled substances in outpatient settings at all. For insomnia (Schedule IV), you can prescribe under physician delegation.
• Florida: PMHNPs require supervising physician protocol. Florida’s ‘autonomous APRN’ law excludes psychiatric NPs — only certain primary care NPs can practice independently.

Practical impact: If you’re a PMHNP in Texas or Florida, you can absolutely treat insomnia via telehealth and prescribe zolpidem or temazepam — but you need a physician partner with a formal agreement on file. Telehealth platforms like Klarity Health handle this infrastructure, pairing NPs with supervising physicians in each state.

State-by-State Telehealth Prescribing Rules for Insomnia

California

Licensing: Must hold CA medical or APRN license. No shortcuts.

Telehealth prescribing: California doesn’t prohibit telehealth prescribing of Schedule IV insomnia meds. State law discourages prescribing Schedule II via telehealth without prior in-person exam, but Schedule IV is fair game if you conduct an appropriate telehealth evaluation meeting the standard of care.

PDMP: Mandatory CURES check before first prescription of any Schedule II–IV controlled substance. Check again every four months for ongoing therapy.

E-prescribing: Required for all controlled substances (with limited exceptions). You’ll need an EPCS-enabled system.

NP independence: Experienced NPs (104 NP status under AB 890) can practice independently, including prescribing insomnia meds. Newer NPs need physician oversight.

Texas

Licensing: Full Texas license required (IMLC available for physicians). APRNs need Texas APRN license plus Prescriptive Authority Agreement.

Telehealth prescribing: Texas prohibits prescribing controlled substances via telehealth for chronic pain management. Insomnia doesn’t fall under this restriction — you can prescribe sleep meds via telehealth legally.

PDMP: Required check before prescribing any opioid, benzodiazepine, barbiturate, or carisoprodol. This includes temazepam or triazolam (benzos). As of 2021, all Schedule III–V drugs trigger PDMP requirements. Check before every new prescription.

E-prescribing: Mandatory for all controlled substances.

NP limitations: Texas NPs cannot prescribe Schedule II in outpatient settings. For Schedule IV insomnia meds, prescribing is allowed under physician delegation. Supervising physician must review cases periodically (can be virtual).

Reality check: Texas is workable for insomnia telehealth, but documentation is critical. Make clear your treatment is for sleep disorder, not pain management, and run PDMP checks religiously.

Florida

Licensing: Either full Florida license OR register as Out-of-State Telehealth Provider (unique Florida option that doesn’t require full licensure).

Telehealth prescribing: Here’s the catch — Florida prohibits prescribing controlled substances via telehealth EXCEPT for:

1. Treatment of a psychiatric disorder
2. Inpatient hospital care
3. Hospice care
4. Nursing home residents

Good news: Insomnia qualifies as a psychiatric disorder under DSM-5 (Insomnia Disorder). You can prescribe Schedule IV sleep medications via telehealth if you document the psychiatric nature of the insomnia.

PDMP: Mandatory E-FORCSE check before every controlled substance prescription to patients age 16+.

NP practice: PMHNPs require supervising physician protocol. Florida’s autonomous APRN law excludes psychiatric NPs. However, only psychiatric nurses can prescribe psychotropic controlled medications to minors in Florida — so your PMHNP certification is essential if treating pediatric insomnia.

Key strategy: Frame your insomnia treatment clearly within psychiatric care. Document DSM-5 diagnosis, address any comorbid anxiety/depression, and your telehealth prescribing fits within Florida’s psychiatric exception.

New York

Licensing: Must hold NY medical or NP license. Not in IMLC.

Telehealth prescribing: No state restrictions on telehealth prescribing of controlled substances beyond federal requirements. Establish proper patient relationship via telehealth, meet standard of care, prescribe away.

PDMP: Mandatory ISTOP PDMP check before every prescription of Schedule II, III, or IV controlled substances. Every. Single. Time.

E-prescribing: Required for all medications (with very limited exceptions).

NP independence: After 3,600 hours practice under collaboration, NPs can practice independently. This is now permanent law (2022). Experienced PMHNPs can operate solo insomnia telehealth practices.

Best practices: New York is telehealth-friendly. Just maintain meticulous PDMP compliance — the state monitors controlled substance prescribing closely.

Pennsylvania

Licensing: PA license required (IMLC available for physicians).

Telehealth prescribing: No state-imposed barriers beyond federal rules. Meet standard of care via telehealth, document appropriately.

PDMP: Required ABC-MAP PDMP check before initially prescribing any opioid or benzodiazepine, then for every subsequent prescription or refill. This is one of the stricter PDMP laws nationally. If you prescribe lorazepam or temazepam for sleep, you check PDMP every time. Recommended for non-benzo Schedule IV like zolpidem too.

NP practice: Pennsylvania is reduced practice. NPs need collaborative agreement with physician for prescriptive authority. Agreement must be on file with State Board of Nursing.

Reality: Pennsylvania has no comprehensive telehealth law but accepts telehealth under standard practice guidelines. For NPs, physician collaboration is non-negotiable.

Illinois

Licensing: Illinois license required (IMLC available for physicians).

Telehealth prescribing: No state restrictions. Provider-patient relationship can be established via telehealth. Prescribe controlled substances if medically appropriate.

PDMP: Providers should check PMPnow (Illinois PDMP) before prescribing controlled substances. Mandatory for opioids; strongly recommended for all controlled drugs. Not as strict as PA or NY, but best practice.

NP independence: Full Practice Authority available after 4,000 hours experience and additional training. FPA-NPs can prescribe controlled substances independently, including insomnia medications. Illinois is one of the most progressive NP states.

Collaborative NPs: Those without FPA need written physician agreement. Can prescribe Schedule III–V with delegation; Schedule II limited to 30-day supply if specifically delegated.

Bottom line: Illinois is favorable for both physicians and experienced NPs. Telehealth is well-established, reimbursement parity is law, and regulatory barriers are minimal.

Practical Compliance Checklist for Insomnia Telehealth

✅ Licensing: Active medical or APRN license in every state where patients are located
✅ DEA registration: Valid DEA number for each state (or single DEA if practicing entirely within one state)
✅ State controlled substance license: Many states require separate state CS registration beyond DEA
✅ PDMP access: Register for and check state PDMP per state requirements before prescribing controlled substances
✅ E-prescribing capability: EPCS-enabled system for controlled substance prescriptions
✅ Collaborative agreements: (NPs in reduced/restricted states) Current written agreement on file
✅ Documentation: Telehealth visits must document same elements as in-person: sleep history, medical screening, diagnosis, treatment rationale
✅ Informed consent: Document patient consent for telehealth treatment
✅ Standard of care: Can you meet the same diagnostic and treatment standard via video as in-person? If not, refer for in-person evaluation

Economic Reality: Why Platform Models Beat DIY Marketing

Let’s talk business. Many providers considering telehealth assume they can build their own practice, run some Google Ads, get listed on Psychology Today, and acquire patients cheaply.

The actual math:

SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. You need content creation, technical optimization, backlink building — typically $2,000–4,000/month through an agency or 15+ hours/week if you DIY. Most solo providers don’t have the expertise or patience.

Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked patients. Factor in click cost, ad management, landing page optimization, and no-shows from cold leads — realistic cost per booked patient is $200–400+.

Directory listings: Psychology Today charges monthly subscription fees and you compete with hundreds of providers on the same page. Zocdoc charges per booking ($35–100+) plus monthly subscription. Your total monthly cost including multiple directories adds up fast.

Failed campaigns: Budget for testing. Most marketing channels require 3–6 months of optimization before positive ROI. That’s $3,000–5,000+ in sunk costs learning what works.

Staff time: Someone has to field calls, qualify leads, handle scheduling, follow up on no-shows. If you’re doing this yourself, that’s billable time you’re not seeing patients.

Total DIY cost: When you honestly calculate agency fees OR your time, ad spend, directory subscriptions, failed tests, and no-show rates, acquiring a qualified psychiatric patient through DIY marketing costs $200–500+ per patient.

Platform economics: Klarity Health and similar platforms use a pay-per-appointment model. You pay a standard listing fee only when a pre-qualified patient books with you. No upfront marketing spend. No monthly subscriptions. No wasted ad spend on clicks that don’t convert.

The value proposition:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform subscription)
• Both insurance and cash-pay patient flow
• Credentialing and billing support
• You control your schedule — only pay when you see patients
• PDMP and e-prescribing tools integrated

Frame it correctly: Instead of gambling $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient books. That’s guaranteed ROI vs risk.

DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling — platforms that handle patient acquisition remove the risk entirely. You focus on clinical care, not becoming a marketing expert.

Common Questions About Insomnia Telehealth Prescribing

Can I prescribe Ambien to a new patient via telehealth without ever meeting them in person?

Yes, through December 31, 2026 under current DEA flexibilities. After that, you’ll likely need to obtain a DEA Special Registration for telemedicine, but prescribing Schedule IV insomnia meds without in-person exams should remain permissible under proposed rules.

Do I need a separate DEA number for each state?

For controlled substances, yes — you need a DEA registration in each state where you practice (where your patients are located), not just where you’re physically located. Each registration costs about $888 for 3 years.

What if a patient is traveling and requests a refill from a different state?

Under DEA rules, you must be registered in the state where the patient is physically located when you prescribe. If a New York patient travels to Florida and needs a refill, you’d need Florida DEA registration and license (or they wait until returning to NY). Many providers advise patients to time refills before travel.

How do I handle patients who might have undiagnosed sleep apnea?

Screen appropriately. Ask about snoring, witnessed apneas, daytime sleepiness (Epworth Scale), BMI, and cardiovascular risk factors. If clinical suspicion for sleep apnea, refer for sleep study before prescribing sedative-hypnotics (which can worsen apnea). Document your clinical reasoning. This is standard of care whether in-person or telehealth.

Can I use phone-only visits to prescribe insomnia medications?

Under current federal rules, video is required for prescribing most controlled substances via telehealth (audio-video telecommunication). Audio-only is permitted only for FDA-approved medications for opioid use disorder (buprenorphine). Some states allowed audio-only for mental health during COVID, but for controlled substance prescribing, stick with video.

What documentation do I need for each telehealth visit?

Same as in-person:

• Chief complaint and sleep history (onset, duration, frequency, impact)
• Relevant medical and psychiatric history
• Medication review (current and past sleep meds, responses, side effects)
• Mental status exam (can be conducted via video)
• Differential diagnosis (ruling out other causes)
• Treatment plan and patient education
• Informed consent for medication risks
• PDMP review and findings
• Electronic prescription sent to pharmacy

What happens if the permanent DEA rules require in-person exams again?

Unlikely for Schedule IV. The proposed ‘Special Registration’ framework specifically allows telehealth prescribing of Schedule III–V without in-person exams for providers who obtain the registration. The DEA recognizes that requiring in-person visits would ‘disrupt patient care’ and create access barriers. More likely scenario: you’ll need to complete a registration process and possibly additional training, but can continue telehealth-only practice for insomnia.

How do I compete with $29/month sleep apps and OTC melatonin?

Don’t compete on price. Position yourself as the specialist for patients who’ve already tried apps, melatonin, sleep hygiene, and still struggle. Your value proposition:

• Accurate diagnosis (differentiating primary insomnia from comorbid conditions)
• Evidence-based treatment (CBT-I combined with appropriate pharmacotherapy)
• Prescription access when needed (many patients need medication to break the cycle)
• Management of complex cases (insomnia + anxiety, depression, ADHD)
• Ongoing monitoring and adjustment

Apps are for people with mild, situational insomnia. You’re for people with chronic insomnia disorder who need clinical expertise.

Next Steps: Building Your Telehealth Insomnia Practice

For psychiatrists:

1. Get licensed in your target states (IMLC can help if available)
2. Obtain DEA registrations in each state
3. Register for state PDMPs and integrate checks into workflow
4. Set up e-prescribing with EPCS capability
5. Decide: DIY marketing (6–12 month timeline, $3,000–5,000/month investment) or platform model (immediate patient flow, pay-per-appointment)

For PMHNPs:

1. Verify your state’s scope — do you need physician collaboration?
2. Secure collaborative agreements if required (or partner with platform that provides this)
3. Obtain DEA registration and state controlled substance license
4. Get PDMP access in each state
5. If in FPA state with sufficient experience, consider independent practice; otherwise, platform models handle physician partnerships

For both:

The path of least resistance in 2026 is joining an established telehealth platform that handles:

• Multi-state licensing support and credentialing
• Patient acquisition and matching
• Integrated telehealth platform with e-prescribing
• PDMP access and compliance tools
• Physician collaboration networks for NPs
• Billing and insurance credentialing

You focus on what you do best: clinical care.

Ready to start seeing insomnia patients via telehealth? Join Klarity Health’s provider network and get matched with pre-qualified patients in your licensed states. No upfront marketing costs. No platform subscription fees. You set your schedule and see patients on your terms.

Sources and References

1. DEA Press Release – ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care’ (December 31, 2025). Available at: https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Vital Care’ (January 16, 2025). Available at: https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Statutes §456.47 – Use of Telehealth to Provide Services. Florida Legislature. Available at: https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Texas Board of Nursing – APRN Practice Frequently Asked Questions. Available at: https://www.bon.texas.gov/faqpracticeaprn.asp.html

5. New York State Education Department, Office of Professions – Nurse Practitioner Practice Requirements. Available at: https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements

Source:

• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=WASHINGTON%20%E2%80%93%C2%A0The%20U,flexibilities%20through%20December%2031%2C%202026
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=Under%20these%20telemedicine%20flexibilities%2C%20DEA,applicable%20federal%20and%20state%20law
• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=During%20the%20COVID,person%20evaluation%20of%20that%20patient
• https://www.dlapiper.com/en-th/insights/publications/2024/11/dea-and-hhs-issue-third-temporary-extension-of-telemedicine-flexibilities#:~:text=Further%2C%20as%20the%20Third%20Temporary,monitor%20this%20space%20for%20updates
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=ever%20having%20an%20in,specialized%20medical%20providers%20to%20issue
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=New%20York%20State%20Education%20Law,to%20practice%20under%20physician%20supervision
• https://idfpr.illinois.gov/profs/nursing.html#:~:text=,APN%20Controlled%20Substance
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=Nurse%20practitioners%2C%20however%2C%20must%20practice,or%20certified%20NP%20as%20follows
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=also%20are%20psychiatric%20nurses%20as,455
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=provider%20may%20not%20use%20telehealth,in%20Schedule%20II%20of%20s